Clicky

Apellis Pharmaceuticals, Inc.(APLS) News

Date Title
May 6 Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
May 1 Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
May 1 Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Apr 30 Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
Apr 26 Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
Apr 23 Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
Apr 1 Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Mar 28 Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
Mar 19 Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
Mar 17 30 Biggest Biotechnology Companies in the World
Mar 14 Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
Mar 11 Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
Mar 11 Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
Feb 15 BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
Feb 14 Has Apellis Pharmaceuticals (APLS) Outpaced Other Medical Stocks This Year?
Feb 13 Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Jan 12 Apellis (APLS): Strong Industry, Solid Earnings Estimate Revisions
Jan 9 Apellis (APLS) Up on Strong Q4 Preliminary Syfovre U.S. Revenues
Jan 9 Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?
Jan 2 Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference